Adaptimmune Therapeutics plc (ADAP) Social Stream



Adaptimmune Therapeutics plc (ADAP): $0.50

0.04 (-7.73%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add ADAP to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#75 of 345

in industry

ADAPTIMMUNE THERAPEUTICS PLC (ADAP) Price Targets From Analysts

Use the tables below to see what analysts covering ADAPTIMMUNE THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-14 5 $17 $7 $10.333 $0.465 2122.15%
2022-02-23 5 $9 $7 $7.666 $0.465 1548.6%
2022-03-14 5 $9 $3 $6.333 $0.465 1261.94%
2022-05-17 5 $9 $2 $6 $0.465 1190.32%
2022-08-04 4 $9 $2 $6 $0.465 1190.32%
2022-09-09 4 $10 $2 $6 $0.465 1190.32%
2022-10-04 4 $10 $1.5 $4.5 $0.465 867.74%
2022-11-09 5 $10 $1.5 $5.875 $0.465 1163.44%
2022-11-14 6 $10 $3 $6.25 $0.465 1244.09%
2023-01-05 7 $10 $3 $6.666 $0.465 1333.55%
2023-03-06 6 $10 $3 $6 $0.465 1190.32%
2023-05-12 6 $10 $2 $5.8 $0.465 1147.31%
2023-08-10 7 $10 $1 $5 $0.465 975.27%
2023-11-08 7 $10 $1 $4.833 $0.465 939.35%

The Trend in the Analyst Price Target


Over the past 42 months, ADAP's average price target has gone down $8.

Over the past 44 weeks, ADAP's average upside potential has been 412.72%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-05 6 10 3 6.666 2.040 226.76%
2023-03-06 6 10 2 5.800 1.320 339.39%
2023-04-17 6 10 2 5.800 1.390 317.27%
2023-08-10 7 10 1 5.000 0.815 513.5%
2023-08-10 7 10 1 4.833 0.815 493.01%

ADAP Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.14 4 0 2 1 1 7

The Trend in the Broker Recommendations


Over the past 13 months, ADAP's average broker recommendation rating worsened by 0.14.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ADAP as an investment opportunity.

  • In terms of how ADAPTIMMUNE THERAPEUTICS PLC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1745.71% of that group.
  • In terms of how ADAPTIMMUNE THERAPEUTICS PLC fares relative to all US stocks, note that its average analyst price target is greater than 101.35% of that group.
  • ADAP has a lower variance in analysts' estimates than -1508.79% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, ADAPTIMMUNE THERAPEUTICS PLC's number of analysts covering the stock is greater than 497.16% of them.

Stocks similar to ADAPTIMMUNE THERAPEUTICS PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OTLK, TTNP, and BCDA.

Is ADAP a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!